FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1837-1838 December 9, 1999 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Messing, E. M. PubMed Citation

The dependence of the growth of prostate cancer on androgens is well documented. Androgen ablation triggers a cascade of biologic events that ends in irreversible damage to the DNA of androgen-sensitive prostate-cancer cells.¹ Such treatment, traditionally reserved for men with metastatic disease, results in major objective and subjective benefits in most patients. However, in approximately 50 percent of patients, disease progression occurs 12 to 18 months after the initiation of treatment, and as a result, survival rates have not increased over the past five decades.² Androgen ablation controls the tumor only temporarily because prostate cancer consists of androgen-dependent and androgen-independent . . . [Full Text of this Article]

References

Related Letters:

Early Hormonal Therapy in Prostate Cancer
Swanson G. P., Messing E. M., Manola J.
Extract | Full Text  
N Engl J Med 2000; 342:1215-1216, Apr 20, 2000. Correspondence

This article has been cited by other articles:

• Castilla, C., Congregado, B., Chinchon, D., Torrubia, F. J., Japon, M. A., Saez, C. (2006). Bcl-xL Is Overexpressed in Hormone-Resistant Prostate Cancer and Promotes Survival of LNCaP Cells via Interaction with Proapoptotic Bak. Endocrinology 147: 4960-4967 [Abstract] [Full Text]  
• Li, X., Marani, M., Mannucci, R., Kinsey, B., Andriani, F., Nicoletti, I., Denner, L., Marcelli, M. (2001). Overexpression of BCL-XL Underlies the Molecular Basis for Resistance to Staurosporine-induced Apoptosis in PC-3 Cells. Cancer Res. 61: 1699-1706 [Abstract] [Full Text]  
• Li, X., Marani, M., Yu, J., Nan, B., Roth, J. A., Kagawa, S., Fang, B., Denner, L., Marcelli, M. (2001). Adenovirus-mediated Bax Overexpression for the Induction of Therapeutic Apoptosis in Prostate Cancer. Cancer Res. 61: 186-191 [Abstract] [Full Text]  
• Swanson, G. P., Messing, E. M., Manola, J. (2000). Early Hormonal Therapy in Prostate Cancer. NEJM 342: 1215-1216 [Full Text]  
• (2000). Early Hormonal Therapy for Node-Positive Prostate Cancer?. JWatch Gastroenterology 2000: 19-19 [Full Text]  
• (1999). Early Hormonal Therapy for Node-Positive Prostate Cancer?. JWatch General 1999: 4-4 [Full Text]